Research use only · Not for human or animal consumption · Qualified purchasers only

Velour Research.
Back to catalog
BBG70 research material vial
lot VRL-BBG70-2604
Each component ≥99% HPLC · RUO

Tissue pathway research

BBG70

BPC-157 + GHK-CU + TB-500

Research blend

A 70 mg multi-peptide research stack combining BPC-157 10 mg, GHK-Cu 50 mg, and TB-500 10 mg in one vial. Positioned for pathway-combination studies spanning connective tissue, fibroblast signaling, and tissue remodeling research.


For laboratory research use only. Not for human or animal consumption, not a drug, food, cosmetic, or supplement. By adding to cart, the researcher affirms compliance with all applicable regulations.

Selected research material

BBG70

70mg vial · SKU VRL-BBG70-70

Lot VRL-BBG70-2604Each component ≥99% HPLC

Choose vial size

COA record

VRL-BBG70-2604

Secure checkout

Waave

Fulfillment

Cold-chain

Research price

$129

RUO only · Lot-matched documentation · Cold-chain handling

Specifications

Molecular formula
Composite blend of BPC-157, GHK-Cu, and TB-500
Molecular weight
6784.88 g/mol
Sequence
BPC-157 (15 aa) · GHK-Cu tripeptide complex · TB-500 fragment
Purity (HPLC)
Each component ≥99%
Appearance
Lyophilized peptide blend
Storage
Store lyophilized at −20 °C, protected from light and moisture
Reconstitution
Reconstitute in sterile diluent appropriate to researcher protocol
Latest lot
VRL-BBG70-2604
Open COA record

BBG70 Research Blend is a combined peptide stack built around three research ingredients that are often discussed together in connective tissue and matrix-biology circles: BPC-157, GHK-Cu, and TB-500. The blend is intended as a single-vial reference for researchers studying overlapping matrix biology, fibroblast, and extracellular matrix pathways rather than isolating one peptide at a time.

Across the underlying literature, BPC-157 has been examined in tendon, ligament, gut, and angiogenic models; GHK-Cu has been studied in fibroblast activation, collagen signaling, and dermal remodeling; and Thymosin β4 / TB-500 has been explored in migration, wound repair, and actin-mediated matrix remodeling models.

Supplied as a research-use-only stack for pathway-combination studies and internal formulation work. Not supplied for human or veterinary use.